News from lupin ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 23, 2014, 13:35 ET

Lupin Appoints Theresa Stevens as Chief Corporate Development Officer

 Pharma major Lupin today announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations....

Apr 23, 2014, 10:46 ET

Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc.

Pharma Major, Lupin Limited (Lupin) announced today that it has entered into a strategic joint venture agreement with Toyama based Japanese...

Apr 21, 2014, 09:42 ET

Lupin Appoints Theresa Stevens as Chief Corporate Development Officer

Pharma major Lupin today announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations....

Mar 27, 2014, 17:42 ET

Lupin adquiere Laboratorios Grin S.A. de C.V., México

Pharma Major Lupin Limited anunció hoy la adquisición del 100% del capital accionario en Laboratorios Grin, S.A. de C.V. (Grin),...

Mar 27, 2014, 16:28 ET

Lupin adquire Laboratorios Grin S.A. De C.V., México

A gigante farmacêutica Lupin Limited anunciou hoje a aquisição de 100% das ações dos Laboratorios Grin, S.A. De C.V....

Mar 27, 2014, 12:24 ET

Lupin Acquires Laboratorios Grin S.A. De C.V., Mexico

Pharma Major Lupin Limited announced today the acquisition of 100% equity stake in Laboratorios Grin, S.A. De C.V. (Grin), Mexico, subject to...

Mar 21, 2014, 12:08 ET

Lupin Launches Generic Niaspan® Tablets in the US

 Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Niacin...

Feb 19, 2014, 09:52 ET

Lupin ernennt Dr. Maurice Chagnaud zum Präsident für Europa und Leiter der Inhalationsstrategie

Pharmakonzern Lupin hat heute die Ernennung von Dr. Maurice Chagnaud als Präsident für Europa und Leiter der Inhalationsstrategie...

Feb 18, 2014, 13:54 ET

Lupin nombra a Maurice Chagnaud presidente de Europa y director de estrategia de inhalación

La farmacéutica Lupin ha anunciado hoy el nombramiento del doctor Maurice Chagnaud como presidente de Europa y director de estrategia de...

Feb 18, 2014, 12:40 ET

Le Dr Maurice Chagnaud nommé président Europe et responsable de la stratégie pour la division Inhalation de Lupin

La société pharmaceutique de premier plan Lupin a annoncé aujourd'hui la nomination du Dr Maurice Chagnaud au poste de...

Feb 18, 2014, 08:05 ET

Lupin Appoints Dr. Maurice Chagnaud as President-Europe & Head of Inhalation Strategy

Pharma major Lupin, today announced the appointment of Dr. Maurice Chagnaud as its President, Europe and Head of Inhalation Strategy. He will be...

Feb 03, 2014, 10:59 ET

Lupin Ltd: Strong Growth, Record Profits - Quarter III Results, FY 2013-14

Net Sales up 21%; EBITDA up 28%; Net profit up 42% Declares Interim Dividend of 150 % Lupin Limited reported its performance for the third...

Dec 18, 2013, 10:26 ET

Lupin Launches Generic Trizivir® Tablets in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary Lupin Pharmaceuticals Inc. has launched its Abacavir Sulfate,...

Dec 12, 2013, 12:08 ET

Lupin Launches Generic Cymbalta® Delayed-Release Capsules 20 mg, 30 mg and 60 mg Strengths in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has launched its Duloxetine...

Nov 11, 2013, 07:07 ET

Lupin Launches Generic Aciphex® Delayed-Release Tablets, 20 mg in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has launched its generic Rabeprazole...

Oct 22, 2013, 12:42 ET

Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules

Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its supplemental New Drug Application (sNDA) for...

Oct 03, 2013, 10:26 ET

Lupin Launches Generic ZYMAXID™ Ophthalmic Solution in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI), has launched its generic...

Sep 23, 2013, 11:25 ET

Lupin Expands US Pediatric Brands Portfolio

Pharmaceutical Major, Lupin Ltd. and its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) announced today that it has signed a...

Aug 08, 2013, 11:07 ET

Lupin weitet Marken-Portfolio aus

Bekanntgabe des Erwerbs der exklusiven US-Rechte an Alinia® für orale Suspension Das große Pharmaunternehmen Lupin Ltd. und seine...

Aug 08, 2013, 07:50 ET

Lupin élargit sa gamme

Annonce de l'acquisition des droits exclusifs d'exploitation aux États-Unis d'Alinia® pour suspension orale. Le géant...